influenza
Antiviral Defense of the Nasal Mucosa Weakens With Age
Prolonged Infection Leads to More Severe Disease
Children With Severe Influenza Produce Little Interferon in the Nose
Mild Influenza Is Associated With Much Higher Interferon Levels
Breastfeeding Protects Infants From Severe Influenza by Activating Type I Interferon Production
The Effect Is Observed for Influenza but Not for RSV or Metapneumovirus
Autoantibodies to Type I Interferons – A Risk Factor for Fatal Avian Influenza H5N1
A Case of Pneumonia in a 71-Year-Old Man
Development of a Universal Influenza A Vaccine
Antigen AC–Anhui Provides Broad Immune Protection
High-Dose Influenza Vaccine Reduces Risk of Cardiovascular Complications in Older Adults
Hospitalization Risk for Heart Failure Decreases by Nearly 20%
Type I and Type III Interferons Disrupt Lung Repair After Viral Infection
Interferon-λ Impairs Lung Barrier Function via p53 Activation
Influenza and COVID-19 – Potential Triggers of Cancer Progression
Respiratory Viruses Elevate IL-6 Levels, Activating Dormant Breast Cancer Cells
CD388 – A New Drug for the Treatment and Prevention of Influenza
The Drug Blocks Neuraminidase and Protects Against a Broad Range of Influenza A and B Viruses
Β-Glucan Reprograms Immunity and Reduces Influenza Severity
Protective effect depends on type I interferon, Dectin-1, and T cells
Influenza During Pregnancy Disrupts Embryonic Brain Development
Severity of Pathology Depends on Viral Load
Type I and III Interferons in Asthma and Exacerbations
Respiratory Infections Trigger Asthma Exacerbations
Naïve Antibodies Provide Protection Against H5Nx Influenza
Naïve B Cells Recognize Hemagglutinin of Avian Influenza
Protection Against Influenza: The Critical Role of Interferon-Lambda
Interferon-λ Signaling in Macrophages is Essential for Antiviral Response to Influenza
Diagnosing ARVI via Interferon Levels
Nasal Interferon Levels Combined with PCR Testing Improve Diagnostic Accuracy to 94%
Vaccines Developed in the Early 2000s May Protect Against New H5N1 Influenza
MF59 and AS03 Adjuvanted Vaccines Induce Cross-Neutralizing Antibodies
Iron Deficiency Suppresses Memory T-Cell Response to Influenza
Iron Deficiency Reduces Interferon-Gamma Production and Weakens Antiviral Defense
COVID-19 Enhances Flu Response by Creating Innate Immune Memory
Coronavirus alters the genetic activity of alveolar macrophages
Different Neurons Control Sneezing and Coughing
Suppressing MrgprC11 Neurons – A New Approach to Treating Allergies and Respiratory Infections
Influenza Virus Utilizes Miz1 Protein to Suppress Interferons
Influenza Boosts Miz1 Levels to Facilitate Unimpeded Replication
Fish Oil Complicates The Course of Influenza
The type of consumed fat matters
Macrophages Shield Against Excessive Inflammation in Respiratory Viral Infections
Macrophages produce oncostatin M and suppress the excessive interferon response
Obesity Disrupts Antiviral Response to Influenza
Adipose tissue hormone suppresses interferon production in macrophages
How Paracetamol Acts in Flu
NSAIDs change neuronal response to influenza, reducing mortality
Simultaneous COVID-19 and Flu: How Coinfection Affects The Outcome of The Disease
Impact of influenza on coronavirus infection
Influenza Virus Interferes with Coronavirus’ Ability to Infect Lungs and Heart
The role of interferon and nitric oxide in the suppression of coronavirus replication
Interferon to Prevent and Treat Respiratory Viral Infections
Review of human studies
Is It Possible to Get Coronavirus and Flu at The Same Time
Coinfection with SARS-CoV-2 and influenza causes life-threatening illness
Influenza vaccination has a positive effect on the survival of patients with cardiovascular diseases
Scientists believe that it is necessary to continue to vaccinate this population group